Enabling you to identify and mitigate the intrinsic risk in your operations, supply chains and business processes.
Evaluating how your products and services meet and exceed quality, safety, sustainability and performance standards.
Validating the specifications, value and safety of your raw materials, products and assets.
Intertek’s Senior Director and Cell Based Assay experts will present at the 13th Annual Applied Pharmaceutical Analysis (APA) Meeting. Meet us at Booth 1.
Intertek’s Senior Director, Dr. Michael H. Buonarati, will present at the 13th Annual APA, September 18 - 20, 2017, Providence, RI, USA. Dr. Buonarati’s presentation will be titled "Development and Validation of Bioanalytical Methods in Ocular Matrices". Intertek’s Natalie Prigozhina, Principal Investigator, Cell Based Assays, will also present a poster titled “Feasibility of a 3D Spheroid Model System for Dynamic and End-Point Drug Testing Readouts”.
Our team of experts in both small molecule and large molecule bioanalysis will be on hand to discuss all bioanalytical topics at Exhibition Booth 1. Our laboratories have been providing Good Laboratory Practice (GLP) compliant bioanalytical services to global pharmaceutical clients supporting their preclinical and clinical studies, and immunogenicity assessment for over 20 years.
Learn more about the Applied Pharmaceutical Analysis Meeting
The Applied Pharmaceutical Analysis (APA) Meeting is organized by the Boston Society, a non-profit organization founded in 2004 as a forum to facilitate education, training, discussion and scientific activities within the industry. The APA Meeting puts an emphasis on attendee programming interest and participation for the annual meeting, which will focus on regulated bioanalysis, discovery sciences, and mechanistic ADME (absorption, distribution, metabolism, and excretion) in the pharmaceutical and biotechnology industries.